Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Wilms Tumor 3Beckwith-Wiedemann Syndrome 1

Interventions

pembrolizumab 20Cisplatin 14Carboplatin 13Paclitaxel 12Radiation 11Doxorubicin 10Radiotherapy 9Nivolumab 9Cyclophosphamide 9Cytarabine 8Vincristine 7Radiotherapy, Intensity-Modulated 7Metformin 7Magnetic Resonance Spectroscopy 7Etoposide 7Leucovorin 6Ipilimumab 6Injections 6Fluorouracil 6Docetaxel 6tislelizumab 5Specimen Handling 5Radiotherapy, Conformal 5Prednisone 5Pemetrexed 5Methotrexate 5Cetuximab 5Bevacizumab 5fludarabine 4durvalumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Dactinomycin × 30 days × Clear all
NCT00352534 2026-06-03

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
808 enrolled 11 charts
Genitourinary

Wilms Tumor

NCT00379340 2026-06-03

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
395 enrolled 15 charts
Genitourinary

Wilms Tumor

NCT00945009 2026-06-03

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

Children's Oncology Group

Phase 3 Completed
249 enrolled 14 charts
Genitourinary

Beckwith-Wiedemann Syndrome, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡